News

Housing-related stocks—homebuilders, home improvement retailers, and building product manufacturers—have underperformed the ...
I'm not reacting to market carnage, I'm just being practical. I'm 75 and my children are firmly established in their lives. My wife and I live in a suburban area in a large house, with a yard and all ...
In the wake of Trump's latest move, consumers now face an overall average U.S. effective tariff rate of 25.3%, the highest level since 1909, according to estimates from the Budget Lab at Yale, a ...
The Trump administration is cancelling the legally-obtained Social Security numbers of immigrant workers, making it effectively impossible for them to work, hold bank accounts or credit cards, rent ...
Even before the most recent chaos, the most common age to claim Social Security benefits was age 62, with 29% of beneficiaries choosing to do this as of 2022, according to the Social Security ...
But those declines come a day after the chip sector had its best day ever, with the PHLX Semiconductor Index SOX rocketing 18.7% after the tariff "pause" announcement. Shares of Nvidia, Broadcom and ...
American depositary receipts of Argenx rose after the company received approval from the Food and Drug Administration for a new delivery method of its treatment for some patients with certain ...
The Trump administration is justifying the shakeup of the SSA by citing concerns about massive fraud against the agency in ...
The IPC Indice de Precios Y Cotizaciones is down 1012.85 points or 1.93% today to 51514.82 --Off 12.26% from its record close of 58711.87 hit Wednesday, Feb. 7, 2024 ...
We are reducing our fair value estimate for narrow-moat Align Technology to $240 per share from $280 against the backdrop of near-term macroeconomic uncertainty and the likely profit and margin ...
--Off 3.32% from its 52-week high of 1.3415 hit Tuesday, Sept. 24, 2024 --Up 6.60% from its 52-week low of 1.2167 hit Friday, Jan. 17, 2025 ...
Health-care companies fell, but not by as much as the broad market, as traders rotated out of high-risk sectors due to economic-growth fears. Swiss pharmaceutical giant Novartis said it plans to ...